• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharma industry news

Mundipharma-EDO

FDA accepts Mundipharma EDO’s IND for EDO-S101

3 August 2015

The FDA has accepted the Mundipharma EDO’s IND for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours...

fst-100

Shire adds FST-100 to pipeline with Foresight acquisition

3 August 2015

Shire has acquired Foresight Biotherapeutics, gaining global rights to FST-100 - a therapy in development for the treatment of infectious conjunctivitis...

cure-c

Celyad completes final patient infusion in Phase III trial of C-Cure

3 August 2015

Celyad has completed the injection procedure for the last patient enrolled in CHART-1, its Phase III clinical trial of cardiovascular candidate, C-Cure...

cell-therapy-catapult

Cell Therapy Catapult awards major contract to CTL

3 August 2015

Cell Therapy Catapult has awarded a contract to CTL to accelerate its clinical programme to develop an engineered T cell treatment for blood cancers...

pancreatic-cancer

Hope for pancreatic cancer urine test

3 August 2015

A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers have found...

telotristat-etiprate

Positive top-line results for Phase 3 telotristat etiprate study

3 August 2015

A Phase 3 clinical trial met its primary endpoint, showing the benefit of oral telotristat etiprate in treating cancer patients with carcinoid syndrome...

antibiotic-resistance

Antibiotic resistance poorly communicated and widely misunderstood

31 July 2015

People in the UK have little awareness of what ‘antibiotic resistance’ means, according to new research commissioned by the Wellcome Trust...

eib-ebola

Ebola vaccine found to have 100% efficacy in a Phase 3 trial

31 July 2015

Merck said today that its Ebola vaccine candidate, rVSV-ZEBOV, was found to have 100% efficacy in an analysis of interim data from a Phase 3 ring trial...

PEGPH20

Eisai and Halozyme to investigate Halaven and PEGPH20 in metastatic breast cancer

31 July 2015

Eisai and Halozyme are to collaborate to evaluate Halaven in combination with PEGPH20 in first line HER2-negative metastatic breast cancer...

cobas-egfr

Roche submits filing to FDA for Cobas EGFR Mutation Test v2

31 July 2015

Roche submitted the cobas EGFR Mutation Test v2 for Premarket Approval (PMA) to the FDA, as a companion diagnostic test for AZD9291...

eribulin

Eisai submits regulatory applications for eribulin in the US, EU and Japan

31 July 2015

Eisai has submitted regulatory applications in the US, EU and Japan for eribulin for the treatment of patients with inoperable soft tissue sarcoma (STS)...

perjeta

Perjeta regimen approved in EU for early stage breast cancer

31 July 2015

The EC has approved the use of Perjeta in combination with Herceptin and chemotherapy for use before surgery in patients with early stage breast cancer...

 

Webinar: Increasing throughput and sensitivity of LC-MS assaysWATCH NOW
+